Yıl: 2018 Cilt: 2 Sayı: 1 Sayfa Aralığı: 2 - 4 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans

Öz:
Prematüre retinopatisi (ROP), retina damarlanması henüz tamamlanmamış immatür retina yapısına sahip prematüre bebeklerde ortaya çıkan bir hastalıktır. ROP, dünya çapında preterm bebeklerin önemli bir bölümünü etkilemektedir. Doğum haftası (DH) ve doğum ağırlıklarının (DA) azalması ile hastalığın insidans ve şiddeti artmaktadır. Bu derlemede ROP'un epidemiyolojik tarihçesi ve sıklık verileri ülkemizde ve yurtdışında yapılan çalışmalar değerlendirilerek özetlenmiştir
Anahtar Kelime:

Konular: Cerrahi

Epidemiology, Prevalence and Incidence in Retinopathy of Prematurity

Öz:
Retinopathy of prematurity (ROP) is a disease that occurs in premature infants with retinal vasculature with an incomplete immature retina structure. ROP affects a substantial number of preterm infants worldwide. Both the incidence and severity increase with decreasing gestational age (GA) and birth weight (BW). In this review, epidemiological history and frequency data of the disease have been summarized after evaluating studies conducted in our country and abroad
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Bibliyografik
  • 1. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheat behind each crystalline lens. Am J Ophthalmol.1942;25:203-4.
  • 2. Jandeck C, Foerster MH. Clinical Course and Treatment. In: Joussen AM, Gardner TW, Kirchhof B, Ryan SJ, eds. Retinal Vascular Diseases, 1st ed. New York:Springer Berlin Heidelberg, 2007;403
  • 3. Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C, Group GR. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth.2010;10 Suppl 1:S1.
  • 4. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet.2012;379(9832):2151-61.
  • 5. Brennan R, Gnanaraj L, Cottrell DG. Retinopathy of prematurity in practice. I: screening for threshold disease. Eye (Lond).2003;17(2):183-8.
  • 6. Holmstrom G, el Azazi M, Jacobson L, Lennerstrand G. A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden. Br J Ophthalmol.1993;77(7):417-23.
  • 7. Schalij-Delfos NE, Zijlmans BL, Wittebol-Post D, Tan KE, Cats BP. Screening for retinopathy of prematurity: do former guidelines still apply? J Pediatr Ophthalmol Strabismus.1996;33(1):35-8.
  • 8. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics.1999;104(3):e26.
  • 9. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology.1991;98(11):1628-40.
  • 10. Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ, et al. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics.2005;115(4):990-6.
  • 11. Haines L, Fielder AR, Baker H, Wilkinson AR. UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome. Arch Dis Child Fetal Neonatal Ed.2005;90(3):F240-4.
  • 12. Todd DA, Wright A, Smith J, Group N. Severe retinopathy of prematurity in infants <30 weeks’ gestation in New South Wales and the Australian Capital Territory from 1992 to 2002. Arch Dis Child Fetal Neonatal Ed.2007;92(4):F251-4.
  • 13. Hellstrom A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet.2013;382(9902):1445-57.
  • 14. Mc Namara JA, Tasman WS. Retinopathy of prematurity. Ophtalmology Clinics of North America.1990;3:413-27.
  • 15. Kinsey VE. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol.1956;56(4):481-543.
  • 16. Lanman JT, Guy LP, Dancis J. Retrolental fibroplasia and oxygen therapy. J Am Med Assoc.1954;155(3):223-6.
  • 17. Avery ME. Recent increase in mortality from hyaline membrane disease. J Pediatr.1960;57:553-9.
  • 18. McDonald AD. Cerebral Palsy in Children of Very Low Birth Weight. Arch Dis Child.1963;38:579-88.
  • 19. Hunter DG, Mukai S. Retinopathy of prematurity: pathogenesis, diagnosis, and treatment. Int Ophthalmol Clin.1992;32(1):163-84.
  • 20. Askin DF, Diehl-Jones W. Retinopathy of prematurity. Crit Care Nurs Clin North Am.2009;21(2):213-33.
  • 21. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev.2008;84(2):77-82.
  • 22. Riise R. Nordic registers of visually impaired children. Scand J Soc Med.1993;21(2):66-8.
  • 23. Campbell PB, Bull MJ, Ellis FD, Bryson CQ, Lemons JA, Schreiner RL. Incidence of retinopathy of prematurity in a tertiary newborn intensive care unit. Arch Ophthalmol.1983;101(11):1686-8.
  • 24. Fielder AR, Shaw DE, Robinson J, Ng YK. Natural history of retinopathy of prematurity: a prospective study. Eye (Lond).1992;6 ( Pt 3):233-42.
  • 25. Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1/2-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol.1993;111(3):339-44.
  • 26. Good WV, Early Treatment for Retinopathy of Prematurity Cooperative G. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc.2004;102:233-48; discussion 48-50.
  • 27. Bas AY, Koc E, Dilmen U, Group ROPNS. Incidence and severity of retinopathy of prematurity in Turkey. Br J Ophthalmol.2015;99(10):1311-4.
  • 28. Ozcan PY, Con R, Celik HT. Türkiye’de Güneydoğu Anadolu Bölgesi Şanlıurfa İlinde Prematüre Retinopatisi Görülme Sıklığı, Risk Faktörleri ve Tedavi Sonuçları. Turkiye Klinikleri J Med Sci.2015;35(4):240-7.
  • 29. Öner A, Özkırıs A, Günes T. Prematüre retinopatisi: 2 yıllık tarama sonuçları- mız. Erciyes Tıp Dergisi.2005;27(3):104-9.
  • 30. Özcan E, Yenice O, Kazokoğlu H, Bavbek T, Toker E, Özek E. Prematüre Retinopatisi Gelişiminde Etkili Risk Faktörleri ve Tarama Sonuçları. RetVit.2006;14(2):127-32.
  • 31. Hanedar A, Göncü T, Adıbelli FM, Çakmak A, Oğuz H. Prematüre Retinopatisi Tarama ve Tedavi Sonuçları. Harran Üniversitesi Tıp Fakültesi Dergisi.2015;12(2):274-80.
  • 32. Demir S, Yucel OE, Niyaz L, Karakus G, Ariturk N. Incidence of retinopathy of prematurity in the middle Black Sea region of Turkey over a 10-year period. J AAPOS.2015;19(1):12-5.
  • 33. Austeng D, Kallen KB, Ewald UW, Jakobsson PG, Holmstrom GE. Incidence of retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden. Arch Ophthalmol.2009;127(10):1315-9.
  • 34. Markestad T, Kaaresen PI, Ronnestad A, Reigstad H, Lossius K, Medbo S, et al. Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics.2005;115(5):1289-98.
  • 35. Rekha S, Battu RR. Retinopathy of prematurity: incidence and risk factors. Indian Pediatr.1996;33(12):999-1003.
  • 36. Larsson E, Holmstrom G. Screening for retinopathy of prematurity: evaluation and modification of guidelines. Br J Ophthalmol.2002;86(12):1399-402.
  • 37. Al-Amro SA, Al-Kharfi TM, Thabit AA, Al-Mofada SM. Retinopathy of prematurity at a University Hospital in Riyadh, Saudi Arabia. Saudi Med J.2003;24(7):720-4.
  • 38. Phan MH, Nguyen PN, Reynolds JD. Incidence and severity of retinopathy of prematurity in Vietnam, a developing middle-income country. J Pediatr Ophthalmol Strabismus.2003;40(4):208-12.
  • 39. Martin Begue N, Perapoch Lopez J.[Retinopathy of prematurity: incidence, severity and outcome]. An Pediatr (Barc).2003;58(2):156-61.
  • 40. Gotz-Wieckowska A, Rydlewska-Fojut M, Siwiec-Proscinska J, Sierzputowska M, Gadzinowski J.[Incidence and the progression of the acute-phase of the retinopathy of prematurity in infants hospitalized in Neonatology Department of University of Medical Sciences in Poznan]. Klin Oczna.2004;106(3 Suppl):498-9.
  • 41. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore.2005;34(2):169-78.
  • 42. Good WV. Screening for retinopathy of prematurity: no ophthalmologist required? Br J Ophthalmol.2000;84(2):127-8.
  • 43. Fortes Filho JB, Eckert GU, Procianoy L, Barros CK, Procianoy RS. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye (Lond).2009;23(1):25-30.
  • 44. Binkhathlan AA, Almahmoud LA, Saleh MJ, Srungeri S. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria. Br J Ophthalmol.2008;92(2):167-9.
APA BİLGEC M, GÜRSOY H, EROL N (2018). Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. , 2 - 4.
Chicago BİLGEC MUSTAFA DEGER,GÜRSOY HALUK HÜSEYİN,EROL NAZMIYE Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. (2018): 2 - 4.
MLA BİLGEC MUSTAFA DEGER,GÜRSOY HALUK HÜSEYİN,EROL NAZMIYE Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. , 2018, ss.2 - 4.
AMA BİLGEC M,GÜRSOY H,EROL N Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. . 2018; 2 - 4.
Vancouver BİLGEC M,GÜRSOY H,EROL N Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. . 2018; 2 - 4.
IEEE BİLGEC M,GÜRSOY H,EROL N "Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans." , ss.2 - 4, 2018.
ISNAD BİLGEC, MUSTAFA DEGER vd. "Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans". (2018), 2-4.
APA BİLGEC M, GÜRSOY H, EROL N (2018). Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. Güncel Retina Dergisi, 2(1), 2 - 4.
Chicago BİLGEC MUSTAFA DEGER,GÜRSOY HALUK HÜSEYİN,EROL NAZMIYE Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. Güncel Retina Dergisi 2, no.1 (2018): 2 - 4.
MLA BİLGEC MUSTAFA DEGER,GÜRSOY HALUK HÜSEYİN,EROL NAZMIYE Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. Güncel Retina Dergisi, vol.2, no.1, 2018, ss.2 - 4.
AMA BİLGEC M,GÜRSOY H,EROL N Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. Güncel Retina Dergisi. 2018; 2(1): 2 - 4.
Vancouver BİLGEC M,GÜRSOY H,EROL N Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans. Güncel Retina Dergisi. 2018; 2(1): 2 - 4.
IEEE BİLGEC M,GÜRSOY H,EROL N "Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans." Güncel Retina Dergisi, 2, ss.2 - 4, 2018.
ISNAD BİLGEC, MUSTAFA DEGER vd. "Prematüre Retinopatisinde Epidemiyoloji, Prevalans ve İnsidans". Güncel Retina Dergisi 2/1 (2018), 2-4.